Nature Publishing Group, publisher of Nature, and other science journals and reference works
Nature
my account e-alerts subscribe register
   
Wednesday 25 November 2009
Journal Home
Current Issue
AOP
Archive
Download PDF
References
Export citation
Export references
Send to a friend
More articles like this

Letters to Nature
Nature 270, 515 - 518 (08 December 1977); doi:10.1038/270515a0

Isolation of a human teratoma cell line which expresses F9 antigen

B. HOGAN*, M. FELLOUS, F. JACOB & P. AVNER

*Imperial Cancer Research Fund, Mill Hill Laboratories, Burtonhole Lane, London, NW7, UK
Unité de Génétique Cellulaire de l'Institut Pasteur et du College de France, 25 rue du Docteur Roux/Hôpital Saint Louis, Paris, 75015, France
Department d'Immunologie et Virologie des Tumeurs, U152, Hôpital Cochin, Rue du Faubourg St Jacques, Paris, 75014, France

THE F9 antigen, defined by antisera raised in syngeneic mice against pluripotent embryonal carcinoma cells, is present on early mouse embryos, spermatozoa and male germinal cells, but not on adult somatic tissues1,2. This antigen, thought to be coded by gene(s) located at, or linked to, the developmentally important T/t complex, may play a part in early embryogenesis3−5. This idea is supported by the fact that the antigen seems to have been conserved during mammalian evolution. Anti-F9 activity is absorbed by sperm of several species including man, rat, rabbit and bull5−7 and there is evidence for its presence on the morulae of rabbit, rat and cow, and on human foetal testicular cells2,5. The cross reaction of anti-F9 with human sperm suggested that undifferentiated stem cells in human teratocarcinomas might also carry F9 on their surface, and we report here the isolation of human teratocarcinoma cell line which expresses F9 antigen.

------------------

References
1. Artzt, K. et al. Proc. natn. Acad. Sci. U.S.A. 70, 2988–2992 (1973).
2. Gachelin, G., Fellous, M., Guenét, J-L. & Jacob, F. Devl Biol. 50, 310–320 (1976).
3. Atrzt, K., Bennett, D. & Jacob, F. Proc. natn. Acad. Sci. U.S.A. 71, 811–814 (1974).
4. Kemler, R. et al. Proc. natn. Acad. Sci. U.S.A. 73, 4080–4084 (1977).
5. Jacob, F. Immun. Rev. 33, 3–32 (1977).
6. Buc-Caron, M-H., Gachelin, G., Hofnung, M. & Jacob, F. Proc. natn. Acad. Sci. U.S.A. 71, 1730–1733 (1974).
7. Fellous, M., Gachelin, G., Buc-Caron, M-H., Dubois, P. & Jacob, F. Devl Biol. 41, 331–337 (1974).
8. Hogan, B. L. M. Nature 263, 136–137 (1976).
9. Clements, G., Klein, G., Zeulhen, J. & Povey, S. Somatic Cell Genet. 2, 309–324 (1976).
10. Janiaud, P., Le Calvez, J. & Aubert, Ch. Annly Derm. Syph. Paris 100, 536–539 (1973).
11. Willis, R. A. Pathology of Tumours, 3rd edn. (Butterworths, London, 1960).
12. Dixon, F. J. & Moore, R. A. Cancer 6, 427–454 (1953).
13. Mostafi, F. K. Rec. Results Cancer Res. 60, 176–195 (1977).
14. Holden, S. et al. Nature, 270, 518–520 (1977).



© 1977 Nature Publishing Group
Privacy Policy